Section Arrow
OSTX.NYSE-M
- OS Therapies Inc
Quotes are at least 15-min delayed:2026/04/23 02:45 EDT
Regular Hours
Last
 1.43
+0.05 (+3.62%)
Day High 
1.46 
Prev. Close
1.38 
1-M High
1.57 
Volume 
532.39K 
Bid
1.44
Ask
1.47
Day Low
1.375 
Open
1.39 
1-M Low
1.16 
Market Cap 
60.19M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.35 
20-SMA 1.36 
50-SMA 1.38 
52-W High 2.57 
52-W Low 1.15 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.98/-0.41
Enterprise Value
60.19M
Balance Sheet
Book Value Per Share
-0.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.2224+0.0256+13.01%-- 
TOVXTheriva Biologics Inc0.3731+0.0344+10.16%0.09PE
IOVAIovance Biotherapeutics3.53-0.17-4.59%-- 
REPLReplimune Group2.27+0.41+22.04%-- 
GERNGeron Corp1.55+0.05+3.33%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new treatments in cancers of the bone in children and young adults. The company has pipeline of product candidates targeting multiple indications for solid cancers including two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps the immune system fight cancer and OST-tADC which is a tunable drug conjugate (tADC) platform currently in preclinical development. Each tADC contains four main components: ligand, payload cassette adaptor, linker and payload.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.